Centessa Pharmaceuticals snaps multi-day losing streak; up 10%

Oct. 20, 2022 2:54 PM ETCentessa Pharmaceuticals plc (CNTA)By: Jonathan Block, SA News Editor

Trading Charts on a Display


  • For the first time since Oct. 13, Centessa Pharmaceuticals (NASDAQ:CNTA) is showing gains.
  • In Thursday afternoon trading, the biotech is up 10%.
  • There is no news or other catalysts that might explain the jump.
  • However, based on a technical analysis, Centessa (CNTA) deviated two standard deviations lower from its mean touching its lower Bollinger Band level and has snapped up higher, back to its mean level.
  • From market close Oct. 13 through market close Oct. 19, shares fell ~15%.
  • Seeking Alpha views Centessa (CNTA) as a hold with high marks for valuation and growth.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.